Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC485

Capivasertib, optionally in the form of a pharmaceutically acceptable salt

  • Status:
    Veitt
  • Application date:
    2.12.2024
  • Application published:
    15.1.2025
  • Grant published:
    15.12.2025
  • Max expiry date:
    24.6.2029
  • Medicine name:
    Truqap - capivasertib
  • Medicine for children:
    No

Timeline

Today
2.12.2024Application
15.1.2025Publication
15.12.2025Registration
24.6.2029Expires

Marketing license

  • IS authorization number:
    EU/1/24/1820
  • Date:
    15.8.2024
  • Foreign authorization number:
    EU/1/24/1820
  • Date:
    17.6.2022

Owner

  • Name:
    AstraZeneca AB
  • Address:
    , 151 85 Södertälje SE

Agent

  • Name:
    Budde Schou A/S
  • Address:
    Dronningens Tværgade 30, 1302 Copenhagen K

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents